Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-04

Clinical Trial Update: Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating azithromycin to prevent post-discharge morbidity and mortality in Kenyan children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of Washington | Conditions: Pneumonia, Diarrhea | Phase 4 | Status: UNKNOWN | Results posted: 2023-12-04